Evaluation of the relationship between insulin resistance and recurrent pregnancy loss

Ginekologia Polska

Volumn 82, Issue 4, 2011, Pages 272-275

  Nazan, Celik ^a   Siddik, Evsen Mehmet ^a   Erdal, Sak Muhammet ^a   Ender, Soydinc ^a   Talip, Gul ^a  

^a DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Etiology; Insulin resistance; Miscarriage; Recurrent

Indexed keywords

EID: 79960367218     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Stirrat G. Recurrent miscarriage. Lancet. 1990, 336, 673-675.
2. Kutteh W. Recurrent pregnancy loss. In: Textbook of Reproductive Medicine. Ed 2. Eds. Carr B, Blackwell R. Stamford, Appleton & Lange. 1998, 679-692.
3. Cocksedge K, Li T, Saravelos S, Metwally M. A reappraisal of the role of polycystic ovary syndrome in recurrent miscarriage. Reprod BioMed Online. 2008, 17, 151-161.
4. Legro R, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocol Metab. 1998, 83, 2694-2698.
5. Hanson R, Pratley R, Bogardus C, [et al.]. Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol. 2000,151, 190-198.
6. Matthews D, Hosker J, Rudenski A, [et al.]. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28, 412-419.
7. Practice Committee of American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss. Revised definition of recurrent pregnancy loss to include two or more spontaneous losses. Fertil Steril. 2008, 90, Suppl 5, S60.
8. Gray R, Wu L. Subfertility and risk of spontaneous abortion. Am J Public Health. 2000, 90,1452-1454.
9. Wang J, Davies M, Norman R. Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment. Hum Reprod. 2001, 16, 2606-2609.
10. Liddell H, Sowden K, Farquhar C. Recurrent miscarriage: screening for polycystic ovaries and subsequent pregnancy outcome. Aust N Z J Obstet Gynaecol. 1997, 37, 402 406.
11. Jakubowi{dotless}cz D, Iuorno M, Jakubowi{dotless}cz S, [et al.]. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab. 2002, 87, 524-529.
12. Glueck C, Phillips H, Cameron D, [et al.]. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study. Fertil Steril. 2001, 75, 46-52.
13. Glueck C, Wang P, Goldenberg N, Sieve-Smith L. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum Reprod. 2002, 17, 2858-2864.
14. Nestler J, Jakubowicz D, Evans W, Pasquali R. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med. 1998, 338, 1876-1880.
15. Tian L, Shen H, Lu Q, [et al.]. Insulin resistance increases the risk of spontaneous abortion after assisted reproduction technology treatment. J Clin Endocrinol Metab. 2007, 92, 1430-1433.
16. Craig L, Ke R, Kutteh W. Increased prevalence of insulin resistance in womenwith history of recurrent pregnancy loss. Fertil Steril. 2002, 78, 487-490.
17. Diejomaoh M, Jirous J, Al-Azemi M, [et al.]. Insulin resistance in women with recurrent spontaneous miscarriage of unknown aetiology. Med Princ Pract. 2007, 16, 114-118.
18. Glueck C, Wang P, Fontaine R, [et al.]. Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome. Metabolism. 1999, 48, 1589-1595.
19. Jakubowicz D, Seppala M, Jakubowicz S, [et al.]. Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome. J Clin Endocrinol Metab. 2001, 86, 1126-1133.